Drug Recall

 

HPS Pharmacies wish to advise that Lundbeck Australia, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall of:

Abilify Maintena® 400mg Therapeutic Kit
Aripiprazole 400mg
ARTG 211150

The only affected batch is batch number 2514152 with an expiry date of April 2019.

This recall has been initiated as 5% of kits from the affected batch experienced a brief temperature excursion. The active ingredient would not have been affected by this temperature excursion and there is a low chance that the water for injections vial may have been damaged.

Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all affected products for correction. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Lundbeck Australia on (02) 8669 1000.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates